Canada · Delayed Price · Currency is CAD Aequus Pharmaceuticals Statistics
Total Valuation
TSXV:AQS has a market cap or net worth of CAD 663,172. The enterprise value is 7.23 million.
| Market Cap | 663,172 |
| Enterprise Value | 7.23M |
Important Dates
The next estimated earnings date is Friday, May 1, 2026.
| Earnings Date | May 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:AQS has 132.63 million shares outstanding.
| Current Share Class | 132.63M |
| Shares Outstanding | 132.63M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.68% |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| PB Ratio | -0.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.01 |
| EV / Sales | 7.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -68.07% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 8.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 12 |
| Asset Turnover | 1.74 |
| Inventory Turnover | 7.59 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is -0.23, so TSXV:AQS's price volatility has been lower than the market average.
| Beta (5Y) | -0.23 |
| 52-Week Price Change | -66.67% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 46.75 |
| Average Volume (20 Days) | 208,793 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:AQS had revenue of CAD 918,468 and -656,339 in losses. Loss per share was -0.00.
| Revenue | 918,468 |
| Gross Profit | 523,043 |
| Operating Income | -574,039 |
| Pretax Income | -656,339 |
| Net Income | -656,339 |
| EBITDA | n/a |
| EBIT | -574,039 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 13,860 in cash and 6.03 million in debt, with a net cash position of -6.02 million or -0.05 per share.
| Cash & Cash Equivalents | 13,860 |
| Total Debt | 6.03M |
| Net Cash | -6.02M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | -6.89M |
| Book Value Per Share | -0.05 |
| Working Capital | -6.89M |
Cash Flow
| Operating Cash Flow | -115,840 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 56.95%, with operating and profit margins of -62.50% and -71.46%.
| Gross Margin | 56.95% |
| Operating Margin | -62.50% |
| Pretax Margin | -71.46% |
| Profit Margin | -71.46% |
| EBITDA Margin | n/a |
| EBIT Margin | -62.50% |
| FCF Margin | n/a |
Dividends & Yields
TSXV:AQS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -98.97% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSXV:AQS has an Altman Z-Score of -299 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -299 |
| Piotroski F-Score | 3 |